Large-scale applications, such as generative AI, recommendation systems, big data, and HPC systems, require large-capacity ...
The painstaking process of formalization to verify proofs is starting to surge thanks to AI. That could radically change the ...
The HARQ program seeks to transform how quantum computing systems are designed and scaled by moving beyond today’s one-qubit-to-rule-them-all approach.
Pioneering computer scientist who devised the Quicksort algorithm, ways of verifying programs and guards against hackers ...
SonoNeu is part of a collaborative project, also comprising six leading US institutions, to advance sonogenetics research Project awarded up to $41.3m by Advanced Research Projects Agency for Health ...
Leading pain researchers at City St George’s, University of London are partnering with Paradigm Biopharmaceuticals, an Australian late-stage clinical development company, to test a drug that could ...
Photo: Edgar Bernard, Inmaculada Fortanet, Noelia Ruiz i Julia Valeiras. The Research Group on Academic and Professional English at the Universitat Jaume I (GRAPE-UJI) is developing a computer tool to ...
Early in the Covid-19 pandemic, the governor of New Jersey made an unusual admission: He’d run out of COBOL developers. The state’s unemployment insurance systems were written in the 60-year-old ...
This Collection provides updated research from Future Computing 2025. This collection will open for submission on 15th June. Papers intended for presentation at the 11th International Conference on ...
In the era of A.I. agents, many Silicon Valley programmers are now barely programming. Instead, what they’re doing is deeply, deeply weird. Credit...Illustration by Pablo Delcan and Danielle Del Plato ...
Apple’s Mac mini is back in the AI headlines. Last month, Perplexity released its own version of the OpenClaw “personal AI assistant” idea with a feature called Perplexity Computer. Now the company is ...
STATEN ISLAND, N.Y., March 9, 2026 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results